Hence, this transporter is likewise discussed to be involved in metal-drug resistance in cancer cells and several studies previously demonstrated decreased amounts of CTR1 in resistant cancer cell models (Song et al., 2004; Zisowsky et al., 2007). Here, SLC31A1 is linked to cancer.